Pediatric hematopoietic SCT in Mexico: recent activity and main problems
| Autor: | C Galindo, Oscar González-Llano, Laura Rodriguez-Romo, A del Campo, Guillermo J. Ruiz-Argüelles, Álvaro Gómez-Peña, Teresa Pompa, Adriana Sandoval, Alberto Olaya, I Montero, José Carlos Jaime-Pérez, Consuelo Mancías-Guerra, Oscar Gonzalez-Ramella, Guadalupe Gonzalez, David Gómez-Almaguer, Guillermo J. Ruiz-Delgado |
|---|---|
| Rok vydání: | 2010 |
| Předmět: |
Gerontology
Transplantation medicine.medical_specialty business.industry medicine.medical_treatment Developing country Hematology Hematopoietic stem cell transplantation University hospital Multidisciplinary team surgical procedures operative immune system diseases Treatment modality hemic and lymphatic diseases Family medicine Mexico city medicine business therapeutics |
| Zdroj: | Bone Marrow Transplantation. 46:607-609 |
| ISSN: | 1476-5365 0268-3369 |
| Popis: | Hematopoietic SCT (HSCT) has become an established therapy for numerous disorders of the hematopoietic system and for some solid tumors.1 However, owing to the high cost of the procedure, and the need for a multidisciplinary team, few centers in developing countries provide this treatment modality. In Mexico, the history of HSCT began in 1980, when the first transplant took place at the National Institute of Nutrition in Mexico City. After this, there were a few other procedures in the National Medical Center of the University Hospital of Monterrey, with poor results. This resulted in the suspension of the HSCT program at these institutions. As a result, the practice of HSCT in Mexico was almost anecdotal until 1995.2 As there has been no national report, we consider it important to evaluate the current activity, needs and perspectives in the field of HSCT. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|